Références bibliographiques

[1]. E. Kaouech et al.,“Pneumocystose à Pneumocystis jiroveci : étude comparée de la PCR et

des techniques de coloration,” Pathol. Biol., vol. 57, no. 5, pp. 373–377, Jul. 2009.
[2]. N. Richard, D. Stamm, and D. Floret, “Pneumocystoses graves en reanimation
pkdiatrique fitude rktrospective 1980-2002,” p. 6.
[3]. Malin A., Gwanzura L., Klein S. et al.Pneumocystis carinii pneumonia
inZimbabweLancet, 1995, 346, 1258-1261. no 39-octobre 95.
[4]. Chagas C. Nova tripanozomiaze humana : estudo sobre a morfolojia e o evolutivo do
Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem.
Mem Inst Oswaldo Cruz (1909) 1, 159-218.
[5]. Delanoë P, Delanoë M. Sur les rapports des kystes d e carinii du poumon des rats avec le
Trypanosoma lewisi. C.R. Acad. Sci. (Paris) (1912) 155, 658-660.
[6]. Aliouat-Denis MC, Chabé M, Demanche C, Aliouat EM, Viscogliosi E, Guillot J,Delhaes
L, Dei-Cas E. Pneumocystis species, co-evolution and pathogenic power. Infect Genet Evol
(2008) 8, 708-726.
[7]. J. R. Stringer, C. B. Beard, R. F. Miller, et A. E. Wakefield, « A New Name for
Pneumocystis from Humans and New Perspectives on the Host-Pathogen Relationship »,
Emerg. Infect. Dis., vol. 8, no 9, p. 891-896, sept. 2002.
[8]. Dei-Cas E. Infections à Pneumocystis carinii : biologie. Encycl Méd Chir, Maladies
infectieuses, 8-590-A-10,1996.
[9]. Chabasse D. Classification des champignons d’intérêt médical. Encycl Méd Chir,
Maladies infectieuses, 8-088-B-10, 2008.
[10]. Latouche S, Diop Santos L, Lacube Ph, Bolognini J, Roux P. Approche moléculaire de
la pneumocystose. Revue Française des Laboratoires 2000 ; 2000 (320) : 63-69.
[11]. Association Française des Enseignants de Parasitologie et Mycologie
(Anofel).Polycopié national de parasitologie, 3eme édition 2007 Available from :
http://www.uvp5.univparis5.fr/campusparasitologie/cycle2/default.asp?frame=s ommaire,
consulté le 24 octobre 2009.
[12]. Gigliotti F, Harmsen AG, Haidaris CG, et al. Pneumocystis carinii is not universally
transmissible between mammalian species. Infect Immun 1993;61:2886–2890.
[13]. Roux P, Latouche S. Épidémiologie moléculaire de la pneumocystose humaine.
Médecine et Maladies Infectieuses 1999;29(12):733-738.
[14]. Keely S, Fischer J, Cushion M, Stringer J. "Phylogenetic identification of Pneumocystis
murina sp. nov., a new species in laboratory mice". Microbiology 2004 ; 150 (Pt 5): 1153–
1165.
[15]. Cushion MT, Keely SP, Stringer JR. "Molecular and phenotypic description of
Pneumocystis wakefieldiae sp. nov., a new species in rats". Mycologia 2004 ; 96 (3): 429–
438.
[16]. Cushion MT, Keely SP, Stringer JR. "Validation of the name Pneumocystis
wakefieldiae". Mycologia 2005 ; 97: 268–268.
[17]. Dei-Cas E et al. "Pneumocystis oryctolagi sp. nov., an uncultured fungus causing
pneumonia in rabbits at weaning: review of current knowledge, and description of a new
taxon on genotypic, phylogenetic and phenotypic bases". FEMS Micriobiol. Rev. 2006 ; 30(6)
: 853–871.
[18]. M. Chabé, I. Durand-Joly, et E. Dei-Cas, « La transmission des infections à
Pneumocystis », médecine/sciences, vol. 28, no 6-7, p. 599-604, juin 2012
[19]. Ruffolo J.J., 1994. Pneumocystis carinii cell structure. In: Walzer, P.D. (Ed.),
Pneumocystis Carinii.
[20] Cushion MT, Walzer PD, Smulian AG, Linke MJ, Ruffolo JJ, Kaneshiro ES, Stringer
JR. Letters to the editor terminology for the life cycle of Pneumocystis carinii. Infect Immun
(1997) 65(10), 4365.
[21]. Aliouat-Denis CM, Martinez A, Aliouat EM, Pottier M, Gantois N, Dei Cas E. The
Pneumocystis life cycle. Mem Inst Oswaldo Cruz. (2009) 104(3), 419-426.
[22]. De Souza W, Benchimol M.Basic biology of Pneumocystis carinii: a mini review. Mem.
Inst. Oswaldo Cruz [online]. 2005 ; 100(8) : 903-908.
[23]. Sidhu GS, Cassai ND, Pei Z. Pneumocystis carinii: An update. Ultrastruct Pathol
2003;27:115-122.
[24]. Wakefield AE. DNA sequences identical to Pneumocystis carinii f. sp. carinii and
Pneumocystis carinii f. sp. hominis in samples of air spora. J Clin Microbiol 1996;34:1754–9.
[25]. Olsson M, Lidman C, Latouche S, Bjo¨rkman A, Roux P, Linder E, et al. Identifi-cation
of Pneumocystis carinii f. sp. hominis gene sequences in air filtrated in hospital environments.
J Clin Microbiol 1998;36:1737–40.
[26]. Latouche S, Olsson M, Polack B, Brun-Pascaud M, Bernard C, Roux P. Detection of
Pneumocystis carinii f. sp. in air samples collected in animal rooms. J Eukaryot Microbiol
1997;44:46–7.
[27]. Casanova-Cardiel L, Leibowitz MJ. Presence of Pneumocystis carinii DNA in pond
water. J Euk Microbial 1997;44:28.
[28]. Gigliotti F, Wright TW. Pneumocystis : where does it live? PLoS Pathog. nov
2012;8(11):e1003025.
[29]. Cushion MT. Are Members of the Fungal Genus Pneumocystis (a) Commensals; (b)
Opportunists; (c) Pathogens; or (d) All of the Above? PLoS Pathog. sept 2010;6(9):e1001009.
[30]. Pifer LL, Hughes WT, Stagno S, Woods D. Pneumocystis carinii infection: evidence for
high prevalence in normal and immunosuppressed children. Pediatrics. janv 1978;61(1):35-
41.
[31]. Respaldiza N, Medrano FJ, Medrano AC, Varela JM, de la Horra C, Montes-Cano M, et
al. High seroprevalence of Pneumocystis infection in Spanish children. Clin Microbiol Infect.
nov 2004;10(11):1029-31.
[32]. Prickartz A, Lüsebrink J, Khalfaoui S, Schildgen O, Schildgen V, Windisch W, et al.
Low Titer Pneumocystis jirovecii Infections: More than Just Colonization? J Fungi (Basel).
mai 2016;2(2).
[33]. Morris A, Norris KA. Colonization by Pneumocystis jirovecii and its role in disease.
Clin Microbiol Rev. avr 2012;25(2):297-317.
[34]. Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of
Pneumocystis colonization. J Infect Dis. janv 2008;197(1):10-7.
[35]. Alanio A, Desoubeaux G, Sarfati C, Hamane S, Bergeron A, Azoulay E, et al. Real-time
PCR assay-based strategy for differentiation between active Pneumocystis jirovecii
pneumonia and colonization in immunocompromised patients. Clin Microbiol Infect. oct
2011;17(10):1531-7.
[36]. Le Gal S, Pougnet L, Damiani C, Fréalle E, Guéguen P, Virmaux M, et al. Pneumocystis
jirovecii in the air surrounding patients with Pneumocystis pulmonary colonization. Diagn
Microbiol Infect Dis. juin 2015;82(2):137-42.
[37]. Morris A, Lundgren JD, Masur H, Walzer PD, Hanson DL, Frederick T, et al. Current
epidemiology of Pneumocystis pneumonia. Emerging Infect Dis. oct 2004;10(10):1713-20.
[38]. Hauser PM, Bille J, Lass-Flörl C, Geltner C, Feldmesser M, Levi M, et al. Multicenter,
prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis
jirovecii infection by use of a commercial real-time PCR assay. J Clin Microbiol. mai
2011;49(5):1872-8.
[39]. Takemoto S, Ebara M, Hasebe S, Yakushijin Y. A study on the colonization of
Pneumocystis jirovecii among outpatients during cancer chemotherapy and among healthy
smokers. J Infect Chemother. nov 2017;23(11):752-6.
[40]. HAS. Évaluation des actes de diagnostic biologique de la pneumocystose.
https://www.has-sante.fr/portail/upload/docs/application/pdf/2017-
10/argumentaire_pneumocystose.pdf, consulté le 20 février 2018.
[41]. Mori S, Cho I, Sugimoto M. A followup study of asymptomatic carriers of
Pneumocystis jirovecii during immunosuppressive therapy for rheumatoid arthritis. J
Rheumatol. août 2009;36(8):1600-5.
[42]. Gigliotti F, Harmsen AG, Wright TW. Characterization of transmission of Pneumocystis
carinii f. sp. muris through immunocompetent BALB/c mice. Infect Immun. juill
2003;71(7):3852-6.
[43]. Hughes WT. Natural mode of acquisition for de novo infection with Pneumocystis
carinii. J Infect Dis. juin 1982;145(6):842-8.
[44]. Wolff L, Horch S, Gemsa D. The development of Pneumocystis carinii pneumonia in
germ-free rats requires immunosuppression and exposure to the Pneumocystis carinii
organism. Comp Immunol Microbiol Infect Dis. janv 1993;16(1):73-6.
[45]. Chabé M, Dei-Cas E, Creusy C, Fleurisse L, Respaldiza N, Camus D, et al.
Immunocompetent hosts as a reservoir of Pneumocystis organisms: histological and rt-PCR
data demonstrate active replication. Eur J Clin Microbiol Infect Dis. févr 2004;23(2):89-97.
[46]. Walzer PD, Schnelle V, Armstrong D, Rosen PP. Nude mouse: a new experimental
model for Pneumocystis carinii infection. Science 1977;197:177—9.
[47]. Choukri F, Menotti J, Sarfati C, Lucet J-C, Nevez G, Garin YJF, et al. Quantification
and spread of Pneumocystis jirovecii in the surrounding air of patients with Pneumocystis
pneumonia. Clin Infect Dis. août 2010;51(3):259-65.
[48]. Rabodonirina M, Vanhems P, Couray-Targe S, Gillibert R-P, Ganne C, Nizard N, et al.
Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal
transplant recipients hospitalized with HIV-infected patients. Emerging Infect Dis. oct
2004;10(10):1766-73.
[49]. Von Kotze C, Sallée M, Jeddi F, Mary C, Moal V, Vacher-Coponat H, et al. Enquête
épidémiologique sur la pneumocystose suite à une épidémie dans un centre de transplantation
rénale. Néphrologie & Thérapeutique. sept 2016;12(5):384-5.
[50]. Carter AM, Enders AC. Comparative aspects of trophoblast development and
placentation. Reprod Biol Endocrinol 2004;2:46 .
[51]. Ng VL, Yajko DM, Hadley WK. Extrapulmonary pneumocystosis. Clin Microbiol Rev
1997;10:401—18.
[52]. Vera C, Aguilar YA, Vélez LA, Rueda ZV. High transient colonization by Pneumocystis
jirovecii between mothers and newborn. Eur J Pediatr. déc 2017;176(12):1619-27.
[53]. Nevez G, Totet A, Pautard JC, Raccurt C. Pneumocystis carinii detection using nested
PCR in nasopharyngeal aspirates of immunocompetent infants with bronchiolitis. J Eukaryot
Microbiol. 2001;Suppl:122S-123S.
[54]. Burgess JW, Kottom TJ, Limper AH. Pneumocystis carinii exhibits a conserved meiotic
control pathway. Infect Immun. janv 2008;76(1):417-25.
[55]. Matsumoto Y, Yoshida Y. Sporogony in Pneumocystis carinii: synaptonemal complexes
and meiotic nuclear divisions observed in precysts. J Protozool. août 1984;31(3):420-8
[56]. Thomas CF, Limper AH. Current insights into the biology and pathogenesis of
Pneumocystis pneumonia. Nat Rev Microbiol. avr 2007;5(4):298-308.
[57]. Roux A, Canet E, Valade S, Gangneux-Robert F, Hamane S, Lafabrie A, et al.
Pneumocystis jirovecii pneumonia in patients with or without AIDS, France. Emerging Infect
Dis. sept 2014;20(9):1490-7.
[58]. Roblot F, Godet C, Le Moal G, Garo B, Faouzi Souala M, Dary M, et al. Analysis of
underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in
immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis. juill
2002;21(7):523-31.